118 related articles for article (PubMed ID: 15196645)
41. Oral absorption of ampicillin: role of paracellular route vs. PepT1 transporter.
Lafforgue G; Arellano C; Vachoux C; Woodley J; Philibert C; Dupouy V; Bousquet-Mélou A; Gandia P; Houin G
Fundam Clin Pharmacol; 2008 Apr; 22(2):189-201. PubMed ID: 18353114
[TBL] [Abstract][Full Text] [Related]
42. Toxicity and gut associated lymphoid tissue translocation of polymyxin B orally administered by alginate/chitosan microparticles in rats.
Coppi G; Bondi M; Coppi A; Rossi T; Sergi S; Iannuccelli V
J Pharm Pharmacol; 2008 Jan; 60(1):21-6. PubMed ID: 18088501
[TBL] [Abstract][Full Text] [Related]
43. The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models.
Foltz M; Cerstiaens A; van Meensel A; Mols R; van der Pijl PC; Duchateau GS; Augustijns P
Peptides; 2008 Aug; 29(8):1312-20. PubMed ID: 18490081
[TBL] [Abstract][Full Text] [Related]
44. Comparison of permeation enhancing strategies for an oral factor Xa inhibitor using the Caco-2 cell monolayer model.
Bruesewitz C; Funke A; Kuhland U; Wagner T; Lipp R
Eur J Pharm Biopharm; 2006 Oct; 64(2):229-37. PubMed ID: 16904877
[TBL] [Abstract][Full Text] [Related]
45. Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method.
Hess S; Rotshild V; Hoffman A
Eur J Pharm Sci; 2005 Jun; 25(2-3):307-12. PubMed ID: 15911227
[TBL] [Abstract][Full Text] [Related]
46. Assessment of intestinal absorption of vitexin-2''-o-rhamnoside in hawthorn leaves flavonoids in rat using in situ and in vitro absorption models.
Xu YA; Fan G; Gao S; Hong Z
Drug Dev Ind Pharm; 2008 Feb; 34(2):164-70. PubMed ID: 18302035
[TBL] [Abstract][Full Text] [Related]
47. Mucoadhesive and penetration enhancement properties of three grades of hyaluronic acid using porcine buccal and vaginal tissue, Caco-2 cell lines, and rat jejunum.
Sandri G; Rossi S; Ferrari F; Bonferoni MC; Zerrouk N; Caramella C
J Pharm Pharmacol; 2004 Sep; 56(9):1083-90. PubMed ID: 15324476
[TBL] [Abstract][Full Text] [Related]
48. Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability.
Zerrouk N; Corti G; Ancillotti S; Maestrelli F; Cirri M; Mura P
Eur J Pharm Biopharm; 2006 Apr; 62(3):241-6. PubMed ID: 16226882
[TBL] [Abstract][Full Text] [Related]
49. Transmucosal macromolecular drug delivery.
Prego C; García M; Torres D; Alonso MJ
J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901
[TBL] [Abstract][Full Text] [Related]
50. Nanoliposomes mediate coenzyme Q10 transport and accumulation across human intestinal Caco-2 cell monolayer.
Xia S; Xu S; Zhang X; Zhong F; Wang Z
J Agric Food Chem; 2009 Sep; 57(17):7989-96. PubMed ID: 19663384
[TBL] [Abstract][Full Text] [Related]
51. N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats).
Thanou M; Florea BI; Langemeÿer MW; Verhoef JC; Junginger HE
Pharm Res; 2000 Jan; 17(1):27-31. PubMed ID: 10714604
[TBL] [Abstract][Full Text] [Related]
52. The chemical species of aluminum influences its paracellular flux across and uptake into Caco-2 cells, a model of gastrointestinal absorption.
Zhou Y; Yokel RA
Toxicol Sci; 2005 Sep; 87(1):15-26. PubMed ID: 15933224
[TBL] [Abstract][Full Text] [Related]
53. Alendronate-loaded microparticles for improvement of intestinal cellular absorption.
Baek JS; Kwon HH; Hwang JS; Sung HC; Lee JM; Shin SC; Kim YR; Cho CW
J Drug Target; 2011 Jan; 19(1):37-48. PubMed ID: 20477555
[TBL] [Abstract][Full Text] [Related]
54. Estimation of the human intestinal permeability of butyltin species using the Caco-2 cell line model.
Azenha MA; Evangelista R; Martel F; Vasconcelos MT
Food Chem Toxicol; 2004 Sep; 42(9):1431-42. PubMed ID: 15234073
[TBL] [Abstract][Full Text] [Related]
55. Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles.
Bravo-Osuna I; Vauthier C; Chacun H; Ponchel G
Eur J Pharm Biopharm; 2008 Jun; 69(2):436-44. PubMed ID: 18395430
[TBL] [Abstract][Full Text] [Related]
56. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
[TBL] [Abstract][Full Text] [Related]
57. Transport of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide by human intestinal Caco-2 cells.
Zhou S; Feng X; Kestell P; Paxton JW; Baguley BC; Chan E
Eur J Pharm Sci; 2005 Apr; 24(5):513-24. PubMed ID: 15784341
[TBL] [Abstract][Full Text] [Related]
58. Effect of dietary fibers on losartan uptake and transport in Caco-2 cells.
Iwazaki A; Takahashi N; Miyake R; Hiroshima Y; Abe M; Yasui A; Imai K
Biopharm Drug Dispos; 2016 May; 37(4):212-9. PubMed ID: 26748460
[TBL] [Abstract][Full Text] [Related]
59. Comparison of ceftibuten transport across Caco-2 cells and rat jejunum mounted on modified Ussing chambers.
Menon RM; Barr WH
Biopharm Drug Dispos; 2003 Oct; 24(7):299-308. PubMed ID: 14520683
[TBL] [Abstract][Full Text] [Related]
60. Chitosan enhances transcellular permeability in human and rat intestine epithelium.
Canali MM; Pedrotti LP; Balsinde J; Ibarra C; Correa SG
Eur J Pharm Biopharm; 2012 Feb; 80(2):418-25. PubMed ID: 22119733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
